Patent 6,299,886

The treatment is by means of nutritional supplements for the adrenal glands, liver and mast cells. The supplements may include potassium, magnesium, Vit B₆, Vit B₅, Vit C and EFA. A biological mechanism linking stress and allergies such as hayfever or other perennial or seasonal respiratory allergies is proposed and the effect of the treatment thereon is discussed.

THE INVENTION

The invention is set out in the claims herein but simply stated the inventor has devised a method of treating stress and/or allergies, such as hayfever and other seasonal or perennial respiratory allergies, by the co-administration, either simultaneously or sequentially, of ingredients comprising potassium, magnesium, Vit B₆, Vit B₅, Vit C and an n-6 or n-3 essential fatty acid (EFA) particularly GLA or DGLA. These ingredients (hereinafter "active ingredients") alone are effective but optionally may be combined with other synergistic nutrients.

The invention also extends to compositions comprising those active ingredients in unit dosage form, effective in the treatment of those conditions, and the use of those active ingredients in the manufacture of a medicament, as a single composition or as sub-compositions for co-administration, for treatment of those conditions. The method composition and use of the invention may be applied to the treatment of a human or non-human (preferably mammalian) animal body.

The active ingredients may be present in combination with any pharmaceutically acceptable carrier and may be in any assimilable form for any particular ingredient as well known to those skilled in the art.

In one embodiment the composition comprises the active ingredients in capsule or other form in amounts as follows, and was administered in daily doses:

    Potassium Gluconate 10 mg to 5000 mg preferably 100 mg to 1000 mg
                                 and very preferably 100 mg to 400 mg.
    Magnesium Oxide    1.0 mg to 1000 mg preferably 10 mg to 500 mg
                              and very preferably 50 mg to 300 mg.
    Pyridoxine             0.1 mg to 500 mg preferably 5 mg to 200 mg
    Hydrochloride        and very preferably 10 mg to 100 mg.
    (Vit B₆)
    Pantothenic Acid   0.l mg to l000 mg preferably 10 mg to 500 mg
    (Vit B₅)         and very preferably 50 mg to 300 mg.
    Ascorbic Acid        10 mg to 5000 mg preferably 100 mg to 2000 mg
    (Vit C)                 and very preferably 500 mg to 1000 mg.
    GLA, for example   10 mg to 5000 mg preferably 100 mg to 2000 mg
    from Evening        and very preferably 400 mg to 1000 mg.
    Primrose Borage
    or Blackcurrant

The following are synergistically supporting ingredients which optionally may be included in the formula:

Fish Oils to supply n-3 EFAs; Vitamins selected from Vit B₁ Thiamine; Vit B₂ Riboflavin; Folic Acid; Vit B₁₂ Cyanocobalamin; Vit B₃ Niacinamide; Vit A Beta Carotene; Vit D Ergocalciferol; Vit E; Biotin; Bioflavonoids; Choline; Inositol; and minerals and trace elements selected from bioavailable forms of Boron; Phosphorus; Manganese; Sodium; Copper; Iron; Zinc; Calcium; Selenium.

The composition may provide the six primary active ingredients alone or may provide these together with one or more of the listed optional minerals and other materials important in the stress response. Vit E may optionally be given in a daily dose of 1 mg to 600 mg, preferably 10 mg to 400 mg and very preferably 10 mg to 50 mg.

The compositions according to the invention may be administered in any convenient form known to those skilled in the art. These forms include capsules of various types, powders, tablets, solutions, suspensions, emulsions and aerosol sprays. The composition may be administered orally, enterally, parenterally or transdermally using appropriate technology known to those skilled in the art. For complete and effective control of allergic symptoms, the composition is intended for administration on a daily basis.

Claim 1 of 8 Claims

What is claimed is:

1. A method of treating an allergy comprising administering a composition comprising potassium gluconate, magnesium oxide, pyridoxine hydrochloride, pantothenic acid, ascorbic acid and an n-3 or n-6 essential fatty acid.

____________________________________________
If you want to learn more about this patent, please go directly to the U.S. Patent and Trademark Office Web site to access the full patent.

[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]